Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Category: Uncategorized
Uncategorized
Latest
Uncategorized
Latest
Color Health Partners with CDC to Increase Access to COVID Testing
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Uncategorized
Latest
Ortho Clinical Diagnostics, Thermo Fisher Scientific Partner on QC Solutions
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
Clinical Chemistry
Latest
Siemens Healthineers Adds Capillary Blood Testing to Core Lab Analyzers
Siemens Healthineers has added CE-marked capillary blood testing for 24 assays to its Atellica core lab analyzers, enabling labs to use finger prick or heel stick samples in place of standard venipuncture.
Flow Cytometry
Latest
ARUP Laboratories Launches Spectral Flow Cytometry Test for Multiple Myeloma Monitoring
The assay is designed to detect minimal residual disease with greater sensitivity than conventional flow cytometry.
Mass Spectrometry
Latest
University of Florida Researchers Develop Rapid Urine Test for Prostate Cancer
The noninvasive method uses paper spray and mass spectrometry to identify disease biomarkers in less than 30 seconds.
Immunoassay
Latest
Alamar Gains Rights to Develop Clinical Alzheimer’s Blood Tests Using ALZpath Antibody
ALZpath and Alamar Biosciences have expanded their partnership, granting Alamar commercial rights to use ALZpath’s pTau217 antibody in clinical blood tests for Alzheimer’s disease.
Molecular Diagnostics
Latest
The Cyclospora Outbreak Is Putting Laboratory Testing to the Test
As Cyclospora infections surge in the US, laboratories face increased pressure to quickly differentiate cases, with the CDC reporting 1,947 confirmed infections and 98 hospitalizations across nine states as of July 24.
Point-of-Care
Latest
Roche Receives FDA Clearance for Point-of-Care Bordetella Test
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.